[与复发相关的候选基因及其与扩散大B细胞淋巴瘤的临床病理联系]

Y X Gong1, Y F Yang1, S N Sun1

  • 1Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

概括

扩散性大B细胞淋巴瘤 (DLBCL) 复发与特定的基因突变有关. PIM1和FAT4突变可能有助于识别复发DLBCL,并指导新的治疗方法.